Azoospermia, a condition affecting male fertility, is characterized by the absence of sperm in semen. It can be classified as obstructive or non-obstructive, each with distinct causes and implications for treatment. Understanding its etiology, diagnosis, and management is crucial for individuals and couples facing challenges with conception.
Azoospermia, the medical condition characterized by the absence of sperm in semen, is treated through various methods at Guru Hospital. Treatment options may include hormone therapy to address underlying hormonal imbalances, surgical interventions such as testicular sperm extraction (TESE) or microsurgical epididymal sperm aspiration (MESA) to retrieve sperm directly from the reproductive system, and assisted reproductive techniques like in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). Guru Hospital offers comprehensive diagnostic evaluations and personalized treatment plans to address the specific needs of individuals with azoospermia, aiming to help them achieve their reproductive goals.
Based on the patient’s condition and for individuals with obstructive azoospermia, surgical procedures like testicular sperm extraction (TESE), MicroTESA and PESA can retrieve sperm directly from the testes, enabling its use in assisted reproductive techniques such as in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). Non-obstructive azoospermia may require hormone therapy to address hormonal imbalances or genetic abnormalities. Assisted reproductive technologies offer viable options for conception when natural methods are not feasible.
At Guru Hospital, we utilize microfluidics technique which has shown promise in various aspects of reproductive medicine and male infertility treatment, including the management of azoospermia. Advanced microfluidic technology is now utilized for selecting superior sperm, reducing the risk of damage. Additionally, the use of the PICSI dish for sperm selection is available at Guru Hospital.
Furthermore, genetic testing empowers clinicians to assess sperm genetic integrity and mitigate the risk of transmitting hereditary conditions to offspring, fostering a comprehensive approach to fertility management for individuals with azoospermia. This helps to avoid the transmission of diseases to the children. We integrate these technologies into their existing infertility treatment protocols, offering patients innovative solutions to address male infertility and improve reproductive outcomes.
